Recipient of federal assistance · DORCHESTER, MA

SYNTIS BIO INC

SYNTIS BIO INC received $2.1M in federal grants and other assistance in FY2026, on 6 actions, −34% vs FY2025. It has no federal contracts in the loaded years. Since FY2024: $6M. Its largest awarding agency was National Institutes of Health ($2.1M).

Assistance · FY2026
$2.1M
New awards
0
Actions
6
Since FY2024
$6M
UEI
NG1VDVGBHC87
Location
DORCHESTER, MA
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 671.9KFY2024
  2. 3.2MFY2025
  3. 2.1MFY2026

By type

  1. Grants$2.1M100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research$2.1M100%

Awarding agencies

  1. National Institutes of Health$2.1M100%
    Department of Health and Human Services

Largest awards

  1. POLYMER EPITHELIAL LINING FOR THE ORAL DELIVERY OF MACROMOLECULES - PROJECT SUMMARY MACROMOLECULE DRUGS, SPECIFICALLY PEPTIDES, ARE AN…$2.8M
    93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Apr 24, 2024 – May 26, 2026· R44DK138869
  2. DEVELOPMENT OF AN ORAL PILL TO MIMIC THE EFFECTS OF GASTRIC BYPASS SURGERY - PROJECT SUMMARY OBESITY IS A COMPLEX DISEASE THAT DISRUPTS…$2.2M
    93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Sep 12, 2024 – Aug 10, 2026· R44DK141341
  3. DEVELOPMENT OF AN ORAL METHIONINE-GAMMA-LYASE ENZYME FOR THE TREATMENT OF HOMOCYSTINURIA - ABSTRACT - DEVELOPMENT OF AN ORAL…$347K
    93.865 · Child Health and Human Development Extramural Research· National Institutes of Health· Project grant· Sep 16, 2025 – Aug 27, 2026· R44HD118842
  4. DEVELOPMENT OF ONCE-DAILY ORAL TREATMENT FOR MAPLE SYRUP URINE DISEASE - PROJECT ABSTRACT SYNTIS BIO IS ADVANCING SYNT-213, A POTENTIALLY…$343.6K
    93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Sep 8, 2025 – Jul 16, 2026· R44DK143766
  5. ORAL THERAPEUTICS PLATFORM FOR TREATING INBORN ERRORS OF AMINO ACID METABOLISM - PROJECT ABSTRACT SYNTIS BIO IS PIONEERING A GROUNDBREAKING…$325K
    93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Jul 23, 2025 – May 6, 2026· R44DK142244

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2024–FY2026.